Medibank Private Ltd
ASX:MPL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medibank Private Ltd
ASX:MPL
|
AU |
|
Thungela Resources Ltd
F:6UP
|
ZA |
|
L
|
Laurentian Bank of Canada
F:LT7
|
CA |
|
ProQR Therapeutics NV
F:0PQ
|
NL |
|
Achieve Life Sciences Inc
NASDAQ:ACHV
|
US |
|
I
|
Intel Corp
BMV:INTC
|
US |
|
G
|
Gobarto SA
WSE:GOB
|
PL |
|
F
|
First Advantage Corp
NASDAQ:FA
|
US |
|
Agora Inc
NASDAQ:API
|
US |
|
U
|
Ulta Beauty Inc
XMUN:34U
|
US |
|
J
|
Jasmine International PCL
SET:JAS
|
TH |
|
VSE Corp
F:VS3
|
US |
Intrinsic Value
Is MPL undervalued or overvalued?
See the intrinsic value estimate for Medibank Private Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
MPL looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with MPL’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Medibank Private Does
Medibank Private Ltd is one of Australia’s largest private health insurers. It sells health insurance policies to individuals, families, and employers, helping pay for hospital care, specialist treatment, and extras such as dental or optical cover. It also offers health-related services that help members manage their care and access medical treatment more easily.
- Headquarters
- Australia AU
- Employees
- 3 604
- IPO date
- Nov 25, 2014
Medibank Private has no economic moat
Customers can compare rival policies and switch without losing waiting periods already served, so inconvenience does little to keep them with Medibank. Bupa, HCF, nib and other funds offer alternatives that compete on price, cover and service.
Read the full moat analysis
The intrinsic value for Medibank Private Ltd (MPL) under the Base Case is hidden AUD.
Compared with the current market price of 4.66 AUD, the stock appears hidden.